Oncolytics reports faster enrollment in REO 033 colorectal cancer studySep 30Regulatory decisionOncolytics BiotechSagimet Biosciences Inc.Updated
Cypherpunk's Leap Therapeutics subsidiary aligns with FDA on Phase 3 trial for sirexatamabAug 12Quarterly updateCypherpunk Technologies Inc.
XBiotech posts results for XB2001 pancreatic cancer trial, over five years after registrationAug 4Trial updateXB2001XBiotech, Inc.
Sign inSign in